Coating processes – Medical or dental purpose product; parts; subcombinations;... – Implantable permanent prosthesis
Reexamination Certificate
2005-08-30
2005-08-30
Beck, Shrive P. (Department: 1762)
Coating processes
Medical or dental purpose product; parts; subcombinations;...
Implantable permanent prosthesis
C427S002250, C427S002300, C623S001490, C623S002420, C623S011110
Reexamination Certificate
active
06936298
ABSTRACT:
The present Specification describes materials and methods which provide for improved performance of medical prostheses, including vascular graft material, artificial heart valves, and other implanted materials. The materials comprising bound thrombomodulin or a functionally equivalent derivative protein, provide for fewer undesirable side effects including inflammation, thromboses and neointimal hyperplasia.
REFERENCES:
patent: 4485045 (1984-11-01), Regen
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4560599 (1985-12-01), Regen
patent: 4880883 (1989-11-01), Grasel et al.
patent: 4906465 (1990-03-01), Chaikof et al.
patent: 5071532 (1991-12-01), Taillet et al.
patent: 5288517 (1994-02-01), Kanno et al.
patent: 5399331 (1995-03-01), Loughrey et al.
patent: 5417969 (1995-05-01), Hsu et al.
patent: 5429618 (1995-07-01), Keogh
patent: 5741325 (1998-04-01), Chaikof et al.
patent: 5755788 (1998-05-01), Strauss
patent: 5911942 (1999-06-01), Fofonoff et al.
patent: 6071532 (2000-06-01), Chaikof et al.
patent: 6171614 (2001-01-01), Chaikof et al.
patent: 6583251 (2003-06-01), Chaikof et al.
patent: 2004/0063200 (2004-04-01), Chaikof et al.
patent: WO 96/21469 (1996-07-01), None
patent: WO 98/16198 (1998-04-01), None
patent: WO 00/00239 (2000-01-01), None
patent: WO 01/78800 (2001-04-01), None
patent: WO 01/80921 (2001-04-01), None
patent: WO 02/09647 (2001-07-01), None
patent: WO 02/055021 (2002-01-01), None
US 5,556,632, 9/1996, Kohler et al. (withdrawn)
Akagawa, M. and Suyama, K., “Mechanism of formation of elastin crosslinks,” (2000)Connect. Tissue Res.41(2):131-141.
Akita, K. et al., Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in NOD/Lt, CBA, and BALB/c mice, (1994)Cell Transplantation3(1):61-73.
Anderson et al., “Bioactive silk-like protein polymer films on silicon devices,” Alper, M., Bayby, H., Kaplan, D. and Navia, M., ed.;Materials Research Society Symp Proc.:Pittsburgh, PA; 1994, 330:171-177.
Andree, H.A.M. et al., “Transport rate limited catalysis on macroscopic surfaces: the activation of factor X in a continuous flow enzyme reactor,” (1994)Biochemistry33(14):4368-4374.
Aoi, K. et al., “Glycopeptide synthesis by an α-amino acid N-carboxyanhydride (NCA) method: ring-opening polymerization of a sugar-substituted NCA,” (1994)Macromolecules27:875-877.
Aoi, K. et al., “Architectural control of sugar-containing polymers by living polymerization: ring-opening polymerization of 2-oxazolines initiated with carbohydrate derivatives,” (1992)Macromolecules25:7073-7075.
Arnander, C. and Olsson, P., “Influence of blood flow and the effect of protamine on the thromboresistant properties of a covalently bonded heparin surface,” (1988)J. Biomed. Mater. Res.22(10):859-868.
Balachander, N. and Sukenik, C.N., “Monolayer transformation by nucleophilic substitution: applications to the creation of new monolayer assemblies,” (1990)Langmuir6(11):1621-1627.
Basmadjian, D, et al., “Coagulation on biomaterials in flowing blood: some theoretical considerations,” (1997)Biomaterials17(23):1511-1522.
Basmadjian, D. and Sefton, M.V., “Relationship between release rate and surface concentration for heparinized materials,” (1983)Journal of Biomedical Materials Research17(3):509-518.
Beyer, D. et al., “Covalently attached polymer mono- and multilayers on silanized glass substrates,” (1996)Thin Solid Films285:825-828.
Bierbaum, K. et al., “A near edge X-ray absorption fine structure spectroscopy and X-ray photoelectron spectroscopy study of the film properties of self-assembled monolayers of organosilanes on oxidized Si(100),” (1995)Langmuir11:512-518.
Biessen, E.A.L. et al., “Synthesis of cluster galactosides with high affinity for the hepatic asialoglycoprotein receptor” (1995)J. Med. Chem.38:1538-1546.
Billy, D. et Al., “Prothrombin activation by prothrombinase in a tubular flow reactor,” (1995)J. Biol. Chem.270(3):1029-1034.
Biro, S. et al., “Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells,” (1994)Circ. Res.74:485-494.
Bitomsky, W. and Wade, R.C., “Docking of glycosaminoglycans to heparin-binding proteins: validation for aFGF, bFGF, and antithrombin and application to IL-8,” (1999)J. Am. Chem. Soc.121:3004-3103.
Björquist, P. et al., “Determination of the inetic constants of tissue factor/factor VII/factor VIIA and antithrombin/heparin using surface plasmon resonance,” (1997)Thromb. Res.85(3):225-236.
Blezer, R. et al., “Initiation and propagation of blood coagulation at artificial surfaces studied in a capillary flow reactor,” (1998)Thromb. Haemostasis79(2):296-301.
Blezer, R. et al., “Activation of blood coagulation at heparin-coated surfaces,” (1997)J. Biomedical Materials Research37(1):108-113.
Bon, S.A.F. and Haddleton, D.M., “Amphiphilic copolymers by atom transfer polymerization with carbohydrate-based initiators and monomers,” (1999)Polym. Prepr.(Am. Chem. Soc., Div. Polym. Chem.) 40(2):248-249.
Bourin, M.C. and Lindahl, U., “Glycosaminoglycans and the regulation of blood coagulation,” (1993)Biochemical J.289(Pt2):313-330.
Brittain, H.A. et al., “Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different,” (1992)J. Lab. Clin. Med.112:538-545.
Broch, H. et al., “Quantum molecular modeling of the elastinic tetrapeptide Val-Pro-Gly-Gly,” (1998)J. Biomol. Struct.&Dyn.15: 1073-1091.
Brown, D.F.M., “Treatment options for deep venous thrombosis,” (Nov. 2001)Emergency Medicine Clinics of North America19(4):913-923.
Brummel, .E. et al., “An integrated study of fibrinogen during blood coagulation,” (1999)J. Biol. Chem.274(32):22862-22870.
Buller, C.E. et al., “Primary stenting versus balloon angioplasty in occluded coronary arteries,” (1999)Circulation100(3):236-242.
Byun, Y. et al., “Binding of antithrombin III and thrombin to immobilized heparin under flow conditions,” (1996)Biotechnology Progress12(2):217-225.
Byun, Y. et al., “Mechanism of thrombin inactivation by immobilized heparin,” (1996)J. Biomed. Mater. Res.30:423-427.
Cai, W.Z. et al., “A solid-state n.m.r. study of microphase structure and segmental dynamics of poly(styrene-b-methylphenysiloxane) diblock copolymers,” (1993)Polymer34:267-276.
Campbell, E.J. et al., “Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer,” (1994)ASAIO J.40(3):M853-M857.
Callstri-Yeh, M. et al., “Thermal stability of self-assembled monolayers from alkytchlorosilanes,” (1996)Langmuir12:2747.
Cao, Q. et al., “Sequence of abductin, the molluscan ‘rubber’ protein,” (1997)Curr. Biol.7:R677-678.
Chaikof, E.L., “Biomaterials that imitate cell microenvironments,” (1996)Chemtech.26:17-24.
Chaikof, E.L. et al., “PEO enhancement of platelet deposition, fibrinogen deposition, and complement C3 activation,” (1992)J. Biomed. Mater. Res.26:1163-1168.
Chang, D.K. et al., “Nuclear overhauser effect and computational characterization of the β-spiral of the polypentapeptide of elastin,” (1989)J. Biomol. Struct. Dyn.6(5):851-858.
Chang, D.K. and Urry, D.W., “Molecular dynamics calculations on relaxed and extended states of the polypentapeptide of elastin,” (1988)Chem. Phys. Lett.147:395-400.
Chapman, D., “Biomembranes and new hemocompatible materials,” (1993)Langmuir9:39-45.
Chen, C. et al., “Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model,” (1997)Ann. Vasc. Surg.11(1):74-79.
Chen, T-M et al., “Studies on the synthesis and properties of novel phospholipid analogous po
Chaikof Elliot L.
Feng June
Liu Hongbo
Orban Janine M.
Sun Xue-Long
Beck Shrive P.
Emory University
Ferber Donna M.
Fletcher, III William Phillip
Greenlee Winner and Sullivan P.C.
LandOfFree
Antithrombogenic membrane mimetic compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antithrombogenic membrane mimetic compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antithrombogenic membrane mimetic compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3517181